Today's top story

EU pharma strategy has patients and collaboration at its heart

Plans to cut the time it takes to gain regulatory approval for medicines and medical devices, and drive the development of new antibiotics and other products for treating rare diseases, have been outlined in a wide-ranging new pharmaceutical strategy for Europe.

Life Sciences & Health

Tailor your content


Most Read

About Out-Law